Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024
June 11, 2024
June 6, 2024
June 5, 2024
May 29, 2024
May 29, 2024
May 22, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 19, 2026
Engineered with the "Integrated Safety" concept and 100% tested via the automated RoboMAG production line, IKA’s new stirrers set a new global standar...
May 19, 2026
Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure...
May 18, 2026
Medix Biochemica’s Board approved a $5 million investment to expand recombinant and cell culture antigen capabilities at its Espoo, Finland and St. Lo...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225